Area of research
Pharmacology · Clinical Psychology
Research interest
Research interests include Cannabis and Cannabinoid Research, Psychedelics and Drug Studies, Substance Abuse Treatment and Outcomes, and Forensic Toxicology and Drug Analysis.
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
Exploring causal mechanisms of psychosis risk
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
Transcultural Aspects of Cannabis Use: a Descriptive Overview of Cannabis Use across Cultures
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
Synthetic Cannabinoid-Related Deaths in England, 2012–2019
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studies
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study
Changes in the composition of cannabis from 2000–2017 in Denmark: Analysis of confiscated samples of cannabis resin.
Cannabis-associated psychosis: Neural substrate and clinical impact
Can we make cannabis safer?
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Towards a Personalized Treatment in Depression: Endocannabinoids, Inflammation and Stress Response
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment